Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2010

01-09-2010 | Original Article

The metabolic profile in patients with skin tags

Authors: Ramazan Sari, Ayse Akman, Erkan Alpsoy, Mustafa Kemal Balci

Published in: Clinical and Experimental Medicine | Issue 3/2010

Login to get access

Abstract

Although skin tags are associated with diabetes mellitus, insulin resistance, hypertension, obesity, atherogenic lipid profile, no data in the literature show that the presence of skin tags is associated with serum high-sensitive C-reactive protein, uric acid, free fatty acid and leptin level. The purpose of this study was to evaluate the frequency of hypertension, dyslipidemia, insulin resistance and obesity in patients with skin tags and to compare patients with skin tags and normal healthy subjects for insulin resistance, serum lipids, insulin, glucose, leptin, high-sensitive C-reactive protein, free fatty acid levels. We evaluated 113 patients with skin tags and 31 healthy subjects. The two groups were compared with respect to BMI, lipid profile, blood pressure, insulin resistance, serum lipids, insulin, glucose, leptin, high-sensitive C-reactive protein, free fatty acid and homeostatic model assessment of insulin resistance (HOMA-IR). Total 53.9 and 33.6% of patients with skin tags were overweight and obese, respectively. The frequency of hypertension 30.1%, dyslipidemia 59.3% and insulin resistance 21.2% were detected. HOMA-IR (P < 0.001) and serum glucose (P < 0.001), insulin (P = 0.002), high-sensitive C-reactive protein (P = 0.001), uric acid (P = 0.001), free fatty acid (P = 0.002), HbA1c (P < 0.001), total cholesterol (P = 0.018), LDL-cholesterol (P = 0.023), and triglyceride levels (P = 0.001) were higher in patients with skin tags than control group. Overweight and/or obesity, dyslipidemia, hypertension, insulin resistance and elevated high-sensitive C-reactive protein are seen in patients with skin tags. Skin tags may be a marker of increased risk of atherosclerosis and cardiovascular disease.
Literature
2.
go back to reference Banik R, Lubach D (1987) Skin tags: localization and frequencies according to sex and age. Dermatologica 174(4):180–183CrossRefPubMed Banik R, Lubach D (1987) Skin tags: localization and frequencies according to sex and age. Dermatologica 174(4):180–183CrossRefPubMed
3.
go back to reference Hidalgo LG (2002) Dermatological complications of obesity. Am J Clin Dermatol 3(7):497–506CrossRef Hidalgo LG (2002) Dermatological complications of obesity. Am J Clin Dermatol 3(7):497–506CrossRef
4.
go back to reference Hud JA, Cohen JB, Wagner JM, Cruz PD Jr (1992) Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 128:941–944CrossRefPubMed Hud JA, Cohen JB, Wagner JM, Cruz PD Jr (1992) Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol 128:941–944CrossRefPubMed
6.
go back to reference Norris PG, McFadden J, Gale E, Griffiths WA (1988) Skin tags are more closely related to fasting insulin than fasting glucose levels. Acta Derm Venereol 68(4):367–368PubMed Norris PG, McFadden J, Gale E, Griffiths WA (1988) Skin tags are more closely related to fasting insulin than fasting glucose levels. Acta Derm Venereol 68(4):367–368PubMed
7.
go back to reference Agarwal JK, Nigam PK (1987) Acrochordon: a cutaneous sign of carbohydrate intolerance. Australas J Dermatol 28(3):132–133CrossRefPubMed Agarwal JK, Nigam PK (1987) Acrochordon: a cutaneous sign of carbohydrate intolerance. Australas J Dermatol 28(3):132–133CrossRefPubMed
8.
go back to reference Kahana M, Grossman E, Feinstein A, Ronnen M, Cohen M, Millet MS (1987) Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 67(2):175–177PubMed Kahana M, Grossman E, Feinstein A, Ronnen M, Cohen M, Millet MS (1987) Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 67(2):175–177PubMed
9.
go back to reference Margolis J, Margolis LS (1976) Skin tags—a frequent sign of diabetes mellitus. N Engl J Med 294(21):1184PubMed Margolis J, Margolis LS (1976) Skin tags—a frequent sign of diabetes mellitus. N Engl J Med 294(21):1184PubMed
10.
go back to reference Hostetter AL (1995) Screening for dyslipidemia. Practice parameter. Am J Clin Pathol 103(4):380–385PubMed Hostetter AL (1995) Screening for dyslipidemia. Practice parameter. Am J Clin Pathol 103(4):380–385PubMed
11.
go back to reference Peters AL (2000) The clinical implications of insulin resistance. Am J Manag Care 6(13):668–674 Peters AL (2000) The clinical implications of insulin resistance. Am J Manag Care 6(13):668–674
12.
go back to reference Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24(3):278–301CrossRefPubMed Fernandez-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24(3):278–301CrossRefPubMed
13.
go back to reference Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–411PubMed Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–411PubMed
14.
go back to reference Thappa DM (1995) Skin tags as markers of diabetes mellitus: an epidemiological study in India. J Dermatol 22(10):729–731PubMed Thappa DM (1995) Skin tags as markers of diabetes mellitus: an epidemiological study in India. J Dermatol 22(10):729–731PubMed
15.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412–419CrossRefPubMed
16.
go back to reference Dianzani C, Calvieri S, Pierangeli A, Imperi M, Bucci M, Degener AM (1998) The detection of human papillomavirus DNA in skin tags. Br J Dermatol 138(4):649–651CrossRefPubMed Dianzani C, Calvieri S, Pierangeli A, Imperi M, Bucci M, Degener AM (1998) The detection of human papillomavirus DNA in skin tags. Br J Dermatol 138(4):649–651CrossRefPubMed
17.
go back to reference Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135CrossRefPubMed Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135CrossRefPubMed
18.
go back to reference Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjets: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue ? Arteriol Thromb Vasc Biol 19:972–978 Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjets: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue ? Arteriol Thromb Vasc Biol 19:972–978
19.
go back to reference Erdogan BS, Aktan S, Rota S, Ergin S, Evliyaoglu D (2005) Skin tags and atherosclerotic risk factors. J Dermatol 32(5):371–375PubMed Erdogan BS, Aktan S, Rota S, Ergin S, Evliyaoglu D (2005) Skin tags and atherosclerotic risk factors. J Dermatol 32(5):371–375PubMed
20.
go back to reference Demir S, Demir Y (2002) Acrochordon and impaired carbohydrate metabolism. Acta Diabetol 39(2):57–59CrossRefPubMed Demir S, Demir Y (2002) Acrochordon and impaired carbohydrate metabolism. Acta Diabetol 39(2):57–59CrossRefPubMed
21.
go back to reference Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95(1):158–166CrossRefPubMed Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95(1):158–166CrossRefPubMed
22.
go back to reference Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100(5):1230–1239CrossRefPubMed Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100(5):1230–1239CrossRefPubMed
23.
go back to reference Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92(1):91–98CrossRefPubMed Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92(1):91–98CrossRefPubMed
24.
go back to reference Shankar SS, Steinberg HO (2005) FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 5(1):30–35CrossRefPubMed Shankar SS, Steinberg HO (2005) FFAs: do they play a role in vascular disease in the insulin resistance syndrome? Curr Diab Rep 5(1):30–35CrossRefPubMed
25.
go back to reference Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 340:448–451CrossRef Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 340:448–451CrossRef
26.
go back to reference Morrow DA, Ridker PM (2000) C-reactive protein, inflammation and coronary risk. Med Clin North Am 84:149–161CrossRefPubMed Morrow DA, Ridker PM (2000) C-reactive protein, inflammation and coronary risk. Med Clin North Am 84:149–161CrossRefPubMed
27.
go back to reference Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrieres J (2002) Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25(8):1371–1377CrossRefPubMed Marques-Vidal P, Mazoyer E, Bongard V, Gourdy P, Ruidavets JB, Drouet L, Ferrieres J (2002) Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25(8):1371–1377CrossRefPubMed
28.
go back to reference Kawamoto R, Tomita H, Oka Y, Ohtsuka N (2006) Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45(9):605–614CrossRefPubMed Kawamoto R, Tomita H, Oka Y, Ohtsuka N (2006) Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45(9):605–614CrossRefPubMed
29.
go back to reference Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27(10):1174–1181CrossRefPubMed Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L (2006) Uric acid and inflammatory markers. Eur Heart J 27(10):1174–1181CrossRefPubMed
30.
go back to reference Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H (2005) Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59(11):1276–1282CrossRefPubMed Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, Sezgin N, Muderrisoglu H (2005) Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59(11):1276–1282CrossRefPubMed
31.
go back to reference Ren J (2004) Leptin and hyperleptinemia-from friend to foe for cardiovascular dysfunction. J Endocrinol 181(1):1–10CrossRefPubMed Ren J (2004) Leptin and hyperleptinemia-from friend to foe for cardiovascular dysfunction. J Endocrinol 181(1):1–10CrossRefPubMed
32.
go back to reference Abdella NA, Mojiminiyi OA, Moussa MA, Zaki M, Al Mohammedi H, Al Ozairi ES, Al Jebely S (2005) Plasma leptin concentration in patients with type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med 22:278–285CrossRefPubMed Abdella NA, Mojiminiyi OA, Moussa MA, Zaki M, Al Mohammedi H, Al Ozairi ES, Al Jebely S (2005) Plasma leptin concentration in patients with type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med 22:278–285CrossRefPubMed
Metadata
Title
The metabolic profile in patients with skin tags
Authors
Ramazan Sari
Ayse Akman
Erkan Alpsoy
Mustafa Kemal Balci
Publication date
01-09-2010
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 3/2010
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-009-0086-5

Other articles of this Issue 3/2010

Clinical and Experimental Medicine 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.